Results 261 to 270 of about 142,066 (310)
Utilisation of cardiopulmonary exercise testing for tailored pulmonary rehabilitation in people with interstitial lung diseases: A systematic review. [PDF]
Bowhay B +6 more
europepmc +1 more source
Diagnostic performance and safety of transbronchial lung cryobiopsy in the study of interstitial lung diseases: a single-center experience. [PDF]
Soto-Feijoo R +9 more
europepmc +1 more source
An update on diagnosis and treatments of childhood interstitial lung diseases. [PDF]
Marczak H +14 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Clinics of North America: Small Animal Practice, 2007
Several noninfectious nonneoplastic interstitial lung diseases (ILDs) have been recognized in dogs and cats. Overall, these ILDs are poorly characterized in dogs and cats, although awareness of the conditions based on descriptions of clinical case series may be increasing.
Carol R, Reinero, Leah A, Cohn
openaire +2 more sources
Several noninfectious nonneoplastic interstitial lung diseases (ILDs) have been recognized in dogs and cats. Overall, these ILDs are poorly characterized in dogs and cats, although awareness of the conditions based on descriptions of clinical case series may be increasing.
Carol R, Reinero, Leah A, Cohn
openaire +2 more sources
Current Opinion in Rheumatology, 2012
Pulmonary fibrosis is a devastating disease that affects millions of people worldwide. Among the most common forms of lung fibrosis are idiopathic pulmonary fibrosis (IPF) and scleroderma-related interstitial lung disease (SSc-ILD). Despite a wealth of literature regarding each of these diseases, studies that directly compare IPF and SSc-ILD are rare ...
Lynne A, Murray +2 more
openaire +2 more sources
Pulmonary fibrosis is a devastating disease that affects millions of people worldwide. Among the most common forms of lung fibrosis are idiopathic pulmonary fibrosis (IPF) and scleroderma-related interstitial lung disease (SSc-ILD). Despite a wealth of literature regarding each of these diseases, studies that directly compare IPF and SSc-ILD are rare ...
Lynne A, Murray +2 more
openaire +2 more sources
Interstitial lung diseases: an overview
2023ILDs represent a heterogeneous group of parenchymal lung diseases. Outcomes vary considerably and range from spontaneous reversibility to progressive pulmonary fibrosis. Timely identification and management are crucial for patients' quality of life and survival.
Karampitsakos, Theodoros +4 more
openaire +1 more source
Imaging of Interstitial Lung Disease
Radiologic Clinics of North America, 2004This article provides a comprehensive summary of typical imaging features of common interstitial lung diseases with an emphasis on high-resolution computed tomography (HRCT). The classification of interstitial lung disease that is used is in accordance with the consensus statement of the American Thoracic Society.
Sudhakar, Pipavath, J David, Godwin
openaire +2 more sources
Childhood Interstitial Lung Disease
Pediatric Allergy, Immunology, and Pulmonology, 2023Childhood interstitial lung disease (chILD) is a heterogeneous group of diseases with various clinical and imaging findings. The incidence and prevalence have increased in recent years, probably due to better comprehension of these rare diseases and increased awareness among physicians.
Halime, Nayir Buyuksahin, Nural, Kiper
openaire +2 more sources
Lung transplantation in interstitial lung disease
Current Opinion in Pulmonary Medicine, 2001Interstitial lung disease is a heterogeneous group of illnesses, some of which may progress to a fibrosing stage and cause respiratory failure. For selected candidates, lung transplantation is the ultimate therapeutic option. We review data on lung transplantation for various interstitial lung diseases.
R, Sulica, A, Teirstein, M L, Padilla
openaire +2 more sources
Lung transplantation for interstitial lung disease
Clinics in Chest Medicine, 2004Lung transplantation remains the only therapeutic option shown to improve survival for many end-stage interstitial lung diseases. Although idiopathic pulmonary fibrosis is the most common indication, transplantation has been performed for many other diseases.
Brandon S, Lu, Sangeeta M, Bhorade
openaire +2 more sources

